Previous close | 0.2000 |
Open | 0.2000 |
Bid | 0.1950 x 0 |
Ask | 0.2000 x 0 |
Day's range | 0.2000 - 0.2000 |
52-week range | 0.1100 - 0.2750 |
Volume | |
Avg. volume | 2,656 |
Market cap | 29.645M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | 25 June 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Devonian Health Group ( CVE:GSD ) Third Quarter 2024 Results Key Financial Results Revenue: CA$5.13m (up by CA$4.72m...
QUEBEC CITY, June 25, 2024--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series in Boston on June 26, 2024 to discuss its latest investor presentation. Devonian welcomes stakeholders, investors, and other individual followers to register and attend this live event.
QUEBEC CITY, June 25, 2024--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its third quarter ended on April 30, 2024.